First, we utilize generative brain models to estimate the combined spatiotemporal influence of Aβ and tau (measured via PET) on neuronal activity (measured through fMRI biomarkers) for cognitively unimpaired and AD participants. The gene discussed is MAPT; the disease is Alzheimer disease.